Received Jul 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 57H54 | — |
Vaccine stored outside recommended conditions and administered to patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a patient who received Men ACWY-CRM NVS (Menveo) (batch number 57H54, expiry date 31-JAN-2026) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced incorrect storage of drug (Verbatim: Vaccine stored outside recommended conditions and administered to patient). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK Receipt Date: 14-JUL-2025 The Licensed Practical Nurse reported that the Menveo 1-vial vaccine had been through a temperature excursion for 78 cumulative hours and reached a temperature was high as 55.8-degree Fahrenheit which led to incorrect storage of drug. The reporter did not mention that a patient was involved but she confused the stability data of the Menveo 1-vial presentation with the stability data of the Menveo 2-vial presentation, thinking that the vaccine Menveo was still stable